Allosteric regulators selectively prevent Ca2+-feedback of CaV and NaV channels

  1. Jacqueline Niu
  2. Ivy E Dick
  3. Wanjun Yang
  4. Moradeke A Bamgboye
  5. David T Yue
  6. Gordon Tomaselli
  7. Takanari Inoue  Is a corresponding author
  8. Manu Ben-Johny  Is a corresponding author
  1. Johns Hopkins University, United States
  2. University of Maryland, United States
  3. Columbia University Medical Center, United States

Abstract

Calmodulin (CaM) serves as a pervasive regulatory subunit of CaV1, CaV2, and NaV1 channels, exploiting a functionally-conserved carboxy-tail element to afford dynamic Ca2+-feedback of cellular excitability in neurons and cardiomyocytes. Yet this modularity counters functional adaptability, as global changes in ambient CaM indiscriminately alter its targets. Here, we demonstrate that two structurally-unrelated proteins, SH3 and cysteine-rich domain (stac) and fibroblast growth factor homologous factors (fhf) selectively diminish Ca2+/CaM-regulation of CaV1 and NaV1 families respectively. The two proteins operate on allosteric sites within upstream portions of respective channel carboxy-tails, distinct from CaM-binding interface. Generalizing this mechanism, insertion of a short RxxK binding motif into CaV1.3 carboxy-tail, confers synthetic switching of CaM regulation by Mona SH3 domain. Overall, our findings identify a general class of auxiliary proteins that modify Ca2+/CaM signaling to individual targets allowing spatial and temporal orchestration of feedback, and outline strategies for engineering Ca2+/CaM signaling to individual targets.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files.

Article and author information

Author details

  1. Jacqueline Niu

    Department of Biomedical Engineering, Johns Hopkins University, Baltimore, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Ivy E Dick

    Department of Physiology, University of Maryland, Baltimore, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Wanjun Yang

    Department of Cardiology, Johns Hopkins University, Baltimore, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Moradeke A Bamgboye

    Department of Physiology, University of Maryland, Baltimore, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. David T Yue

    Department of Biomedical Engineering, Johns Hopkins University, Baltimore, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Gordon Tomaselli

    Department of Cardiology, Johns Hopkins University, Baltimore, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Takanari Inoue

    Department of Cell Biology, Johns Hopkins University, Baltimore, United States
    For correspondence
    jctinoue@jhmi.edu
    Competing interests
    The authors declare that no competing interests exist.
  8. Manu Ben-Johny

    Department of Physiology and Cellular Biophysics, Columbia University Medical Center, New York, United States
    For correspondence
    mbj2124@cumc.columbia.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5645-0815

Funding

National Institute of Mental Health

  • David T Yue
  • Manu Ben-Johny

National Heart, Lung, and Blood Institute

  • Gordon Tomaselli
  • Manu Ben-Johny

National Science Foundation

  • Jacqueline Niu

National Institute of Neurological Disorders and Stroke

  • Ivy E Dick
  • David T Yue

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the animals were handled according to approved institutional animal care and use committee (IACUC) protocols of the Johns Hopkins University (GP15M172). The protocol was approved by the Committee on the Ethics of Animal Experiments of the Johns Hopkins University. All surgery was performed under sodium pentobarbital anesthesia, and every effort was made to minimize suffering.

Copyright

© 2018, Niu et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,810
    views
  • 323
    downloads
  • 34
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Jacqueline Niu
  2. Ivy E Dick
  3. Wanjun Yang
  4. Moradeke A Bamgboye
  5. David T Yue
  6. Gordon Tomaselli
  7. Takanari Inoue
  8. Manu Ben-Johny
(2018)
Allosteric regulators selectively prevent Ca2+-feedback of CaV and NaV channels
eLife 7:e35222.
https://doi.org/10.7554/eLife.35222

Share this article

https://doi.org/10.7554/eLife.35222

Further reading

    1. Structural Biology and Molecular Biophysics
    Giuseppe Deganutti, Ludovico Pipito ... Christopher Arthur Reynolds
    Research Article

    The structural basis for the pharmacology of human G protein-coupled receptors (GPCRs), the most abundant membrane proteins and the target of about 35% of approved drugs, is still a matter of intense study. What makes GPCRs challenging to study is the inherent flexibility and the metastable nature of interaction with extra- and intracellular partners that drive their effects. Here, we present a molecular dynamics (MD) adaptive sampling algorithm, namely multiple walker supervised molecular dynamics (mwSuMD), to address complex structural transitions involving GPCRs without energy input. We first report the binding and unbinding of the vasopressin peptide from its receptor V2. Successively, we present the complete transition of the glucagon-like peptide-1 receptor (GLP-1R) from inactive to active, agonist and Gs-bound state, and the guanosine diphosphate (GDP) release from Gs. To our knowledge, this is the first time the whole sequence of events leading from an inactive GPCR to the GDP release is simulated without any energy bias. We demonstrate that mwSuMD can address complex binding processes intrinsically linked to protein dynamics out of reach of classic MD.

    1. Structural Biology and Molecular Biophysics
    Mia L Abramsson, Robin A Corey ... Michael Landreh
    Research Article

    Integral membrane proteins carry out essential functions in the cell, and their activities are often modulated by specific protein-lipid interactions in the membrane. Here, we elucidate the intricate role of cardiolipin (CDL), a regulatory lipid, as a stabilizer of membrane proteins and their complexes. Using the in silico-designed model protein TMHC4_R (ROCKET) as a scaffold, we employ a combination of molecular dynamics simulations and native mass spectrometry to explore the protein features that facilitate preferential lipid interactions and mediate stabilization. We find that the spatial arrangement of positively charged residues as well as local conformational flexibility are factors that distinguish stabilizing from non-stabilizing CDL interactions. However, we also find that even in this controlled, artificial system, a clear-cut distinction between binding and stabilization is difficult to attain, revealing that overlapping lipid contacts can partially compensate for the effects of binding site mutations. Extending our insights to naturally occurring proteins, we identify a stabilizing CDL site within the E. coli rhomboid intramembrane protease GlpG and uncover its regulatory influence on enzyme substrate preference. In this work, we establish a framework for engineering functional lipid interactions, paving the way for the design of proteins with membrane-specific properties or functions.